BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19618291)

  • 1. Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells.
    Di JM; Pang J; Sun QP; Zhang Y; Fang YQ; Liu XP; Zhou JH; Ruan XX; Gao X
    Mol Biol Rep; 2010 Apr; 37(4):1849-55. PubMed ID: 19618291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
    Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
    Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
    Arunkumar N; Liu C; Hang H; Song W
    Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
    Ilvesaro JM; Merrell MA; Swain TM; Davidson J; Zayzafoon M; Harris KW; Selander KS
    Prostate; 2007 May; 67(7):774-81. PubMed ID: 17373717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
    Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
    Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of TLR9 in esophageal cancer.
    Zhang Y; Wang Q; Ma A; Li Y; Li R; Wang Y
    Oncol Rep; 2014 May; 31(5):2298-304. PubMed ID: 24647486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A; Esteves H; Curnow SJ; Browning MJ
    Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-kappaB-independent pathways.
    Kim JM; Kim NI; Oh YK; Kim YJ; Youn J; Ahn MJ
    Int Immunol; 2005 Dec; 17(12):1525-31. PubMed ID: 16263754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturated fatty acids up-regulate COX-2 expression in prostate epithelial cells via toll-like receptor 4/NF-κB signaling.
    Liu J; Hu S; Cui Y; Sun MK; Xie F; Zhang Q; Jin J
    Inflammation; 2014 Apr; 37(2):467-77. PubMed ID: 24221358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
    Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W; Yamazaki T; Nishida Y; Hanagata N
    BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells.
    Zhang J; Zhu QL; Huang P; Yu Q; Wang ZH; Cooper PR; Smith AJ; He W
    Int Endod J; 2013 Jul; 46(7):666-74. PubMed ID: 23331101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.
    Wen X; Chao C; Ives K; Hellmich MR
    BMC Mol Biol; 2011 Jul; 12():29. PubMed ID: 21745389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
    J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.
    Lim EJ; Lee SH; Lee JG; Kim JR; Yun SS; Baek SH; Lee C
    Exp Mol Med; 2007 Apr; 39(2):239-45. PubMed ID: 17464186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.
    Amcheslavsky A; Zou W; Bar-Shavit Z
    J Biol Chem; 2004 Dec; 279(52):54039-45. PubMed ID: 15485822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.